andrographolide: Clinical Trials

2 trials of andrographolide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 unknown. 2 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Unknown 1
Phase 22Completed 1, Unknown 1

Follow andrographolide: new trials by email Literature Review of andrographolide trials Research Report on andrographolide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS
Andrographolides, placebo - Primary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive
Phase 1 / Phase 2UnknownInnobioscience SpA682014-09-012014-10-27
Efficacy Study of Andrographis Paniculata Purified Standardized Extract (ApE) in Patients With Multiple Sclerosis (MS)
1 - Andrographis paniculata p/st extract, 2 - Excipients - Multiple Sclerosis, Relapsing-Remitting
Phase 1 / Phase 2CompletedUniversidad Austral de Chile302012-01-012016-06-23

Conditions studied

Multiple Sclerosis, Chronic Progressive (1)  ·  Multiple Sclerosis, Relapsing-Remitting (1)  ·  Nervous System Diseases (1)

Sponsors

Innobioscience SpA (1)  ·  Universidad Austral de Chile (1)

Countries

Chile (2)

Top investigators

Juan L Hancke, DVM, PhD (1)  ·  Juan L. Hancke, PhD (1)

Results publications

PMID 27215274, PMID 32380977